Suchergebnisse - "Spiekermann, Karsten"

PubPharm (10)

1

Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia

enthalten in: Scientific reports | 2019

von Batcha, A. | Bamopoulos, S. | Kerbs, P. | +19

2

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

enthalten in: Blood | 2018

von Herrmann, M. | Krupka, C. | Deiser, K. | +11

CommentIn: Blood. 2018 Dec 6;132(23):2425-2427. - PMID 30523124

3

Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens

enthalten in: Clinical lymphoma, myeloma & leukemia | 2017

von Hecht, A. | Doll, S. | Altmann, H. | +10

4

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

enthalten in: Blood | 2014

von Herold, T. | Metzeler, K. | Vosberg, S. | +25

5

In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival

enthalten in: Leukemia research | 2013

von Nolte, F. | Hecht, A. | Reinwald, M. | +9

6

ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia : a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Metzeler, K. | Dufour, A. | Benthaus, T. | +12

7

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

enthalten in: Blood | 2008

von Metzeler, K. | Hummel, M. | Bloomfield, C. | +19

8

KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor

enthalten in: Blood | 2005

von Kohl, T. | Schnittger, S. | Ellwart, J. | +2

9

A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia

enthalten in: Blood | 2002

von Spiekermann, K. | Bagrintseva, K. | Schoch, C. | +3

10

The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells

enthalten in: Experimental hematology | 2002

von Spiekermann, K. | Faber, F. | Voswinckel, R. | +1

1
[1]